Clinical Trial Update: Assessment of Grazax® Treatment Compliance [Phase 3]

View source ↗

Summary

Phase 3 trial assessing Grazax treatment compliance in allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• GRAZAX (birch pollen sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED